Are they safe
During AOD 9604 and tirzepatide combination therapy, resistance training becomes even more important because the aggressive fat loss rate means the body will readily catabolize muscle if it is not receiving the stimulus to maintain it
For a 70 kg individual, this translates to approximately 1.75-28 mg per dose, though standard therapeutic protocols use significantly lower daily doses
Deep abdominal fat, which responds well to beta-3 adrenergic stimulation, appears particularly susceptible during combination therapy
There may be instances where certain conditions, such as poor nutrition, intestinal issues, infections, and cancer, may lead to B12 deficiency
Unit size: 10 mg per vial